Published in PLoS Biol on February 23, 2010
Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature (2013) 3.69
Platforms for antibiotic discovery. Nat Rev Drug Discov (2013) 3.66
Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci U S A (2011) 3.52
Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl Environ Microbiol (2011) 2.19
Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol (2010) 2.11
Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev (2013) 2.01
Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. Proc Natl Acad Sci U S A (2012) 1.74
A problem of persistence: still more questions than answers? Nat Rev Microbiol (2013) 1.68
A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS. Nat Chem Biol (2012) 1.67
Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio (2011) 1.64
Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells. Mol Cell (2016) 1.61
Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection. J Clin Microbiol (2012) 1.53
Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother (2013) 1.51
Microbial population and community dynamics on plant roots and their feedbacks on plant communities. Annu Rev Microbiol (2012) 1.50
Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr Opin Microbiol (2011) 1.47
ATP-Dependent Persister Formation in Escherichia coli. MBio (2017) 1.46
Persisters, persistent infections and the Yin-Yang model. Emerg Microbes Infect (2014) 1.44
To be or not to be: regulation of restriction-modification systems and other toxin-antitoxin systems. Nucleic Acids Res (2013) 1.42
Role of oxidative stress in persister tolerance. Antimicrob Agents Chemother (2012) 1.40
Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob Agents Chemother (2011) 1.40
Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence. J Bacteriol (2011) 1.38
An expanding universe of small proteins. Curr Opin Microbiol (2011) 1.35
Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother (2013) 1.33
Bacterial persister cell formation and dormancy. Appl Environ Microbiol (2013) 1.28
Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLoS Genet (2013) 1.23
Vibrio cholerae triggers SOS and mutagenesis in response to a wide range of antibiotics: a route towards multiresistance. Antimicrob Agents Chemother (2011) 1.22
"Persisters": survival at the cellular level. PLoS Pathog (2011) 1.19
Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet (2013) 1.16
Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev (2014) 1.16
Artificial activation of toxin-antitoxin systems as an antibacterial strategy. Trends Microbiol (2012) 1.15
Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol (2016) 1.12
Salmonellae interactions with host processes. Nat Rev Microbiol (2015) 1.11
A cis-antisense RNA acts in trans in Staphylococcus aureus to control translation of a human cytolytic peptide. Nat Struct Mol Biol (2011) 1.10
Stochastic induction of persister cells by HipA through (p)ppGpp-mediated activation of mRNA endonucleases. Proc Natl Acad Sci U S A (2015) 1.10
Biofilm-specific antibiotic tolerance and resistance. Eur J Clin Microbiol Infect Dis (2015) 1.09
Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells. Antimicrob Agents Chemother (2015) 1.08
Culture history and population heterogeneity as determinants of bacterial adaptation: the adaptomics of a single environmental transition. Microbiol Mol Biol Rev (2012) 1.07
Bacterial persistence increases as environmental fitness decreases. Microb Biotechnol (2012) 1.06
Concentration-dependent activity of antibiotics in natural environments. Front Microbiol (2013) 1.06
Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? Curr Opin Microbiol (2010) 1.06
The intrinsic resistome of bacterial pathogens. Front Microbiol (2013) 1.05
A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance. J Bacteriol (2012) 1.05
Inflammation and vitamin D: the infection connection. Inflamm Res (2014) 1.05
Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence (2013) 1.04
Type II toxin/antitoxin MqsR/MqsA controls type V toxin/antitoxin GhoT/GhoS. Environ Microbiol (2013) 1.03
Mannitol enhances antibiotic sensitivity of persister bacteria in Pseudomonas aeruginosa biofilms. PLoS One (2013) 1.02
Pseudomonas aeruginosa biofilms in disease. Microb Ecol (2013) 1.02
Genetic basis of persister tolerance to aminoglycosides in Escherichia coli. MBio (2015) 0.99
Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides. Appl Environ Microbiol (2011) 0.96
Regulation of the Escherichia coli HipBA toxin-antitoxin system by proteolysis. PLoS One (2012) 0.96
Interconversion between bound and free conformations of LexA orchestrates the bacterial SOS response. Nucleic Acids Res (2011) 0.95
Tolerance of Escherichia coli to fluoroquinolone antibiotics depends on specific components of the SOS response pathway. Genetics (2013) 0.95
Targeting dormant bacilli to fight tuberculosis. Mediterr J Hematol Infect Dis (2013) 0.95
MazF-induced growth inhibition and persister generation in Escherichia coli. J Biol Chem (2013) 0.94
The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations. PLoS Pathog (2013) 0.93
Inhibition of stationary phase respiration impairs persister formation in E. coli. Nat Commun (2015) 0.93
The ζ toxin induces a set of protective responses and dormancy. PLoS One (2012) 0.91
Detection of transcriptional triggers in the dynamics of microbial growth: application to the respiratorily versatile bacterium Shewanella oneidensis. Nucleic Acids Res (2012) 0.91
RelE-mediated dormancy is enhanced at high cell density in Escherichia coli. J Bacteriol (2011) 0.91
Metabolic aspects of bacterial persisters. Front Cell Infect Microbiol (2014) 0.91
The Role of Efflux and Physiological Adaptation in Biofilm Tolerance and Resistance. J Biol Chem (2016) 0.91
A quorum sensing small volatile molecule promotes antibiotic tolerance in bacteria. PLoS One (2013) 0.91
The formation of persister cells in stationary-phase cultures of Escherichia coli is associated with the aggregation of endogenous proteins. PLoS One (2013) 0.90
Persistence Increases in the Absence of the Alarmone Guanosine Tetraphosphate by Reducing Cell Growth. Sci Rep (2016) 0.90
de novo synthesis of a bacterial toxin/antitoxin system. Sci Rep (2014) 0.89
Nutrient transitions are a source of persisters in Escherichia coli biofilms. PLoS One (2014) 0.89
The Escherichia coli toxin MqsR destabilizes the transcriptional repression complex formed between the antitoxin MqsA and the mqsRA operon promoter. J Biol Chem (2012) 0.89
The HicA toxin from Burkholderia pseudomallei has a role in persister cell formation. Biochem J (2014) 0.88
Heterogeneous persister cells formation in Acinetobacter baumannii. PLoS One (2013) 0.88
sRNA antitoxins: more than one way to repress a toxin. Toxins (Basel) (2014) 0.88
Enhancing the utility of existing antibiotics by targeting bacterial behaviour? Br J Pharmacol (2012) 0.88
RalR (a DNase) and RalA (a small RNA) form a type I toxin-antitoxin system in Escherichia coli. Nucleic Acids Res (2014) 0.88
Novel protocol for persister cells isolation. PLoS One (2014) 0.88
Persisters-as elusive as ever. Appl Microbiol Biotechnol (2016) 0.87
Single transmembrane peptide DinQ modulates membrane-dependent activities. PLoS Genet (2013) 0.87
Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens. Antimicrob Agents Chemother (2014) 0.87
DNA damage responses in prokaryotes: regulating gene expression, modulating growth patterns, and manipulating replication forks. Cold Spring Harb Perspect Biol (2013) 0.87
Persister-promoting bacterial toxin TisB produces anion-selective pores in planar lipid bilayers. FEBS Lett (2012) 0.87
Antibiotic transport in resistant bacteria: synchrotron UV fluorescence microscopy to determine antibiotic accumulation with single cell resolution. PLoS One (2012) 0.87
Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes. Appl Environ Microbiol (2013) 0.87
Isolation of highly persistent mutants of Salmonella enterica serovar typhimurium reveals a new toxin-antitoxin module. J Bacteriol (2012) 0.86
Peptide-lipid interactions of the stress-response peptide TisB that induces bacterial persistence. Biophys J (2012) 0.86
Toxin-Antitoxin Systems in Clinical Pathogens. Toxins (Basel) (2016) 0.86
One antitoxin--two functions: SR4 controls toxin mRNA decay and translation. Nucleic Acids Res (2013) 0.85
Persister Development by Borrelia burgdorferi Populations In Vitro. Antimicrob Agents Chemother (2015) 0.85
Persistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibiotics. Curr Opin Microbiol (2014) 0.85
Additional role for the ccd operon of F-plasmid as a transmissible persistence factor. Proc Natl Acad Sci U S A (2012) 0.85
The ZorO-OrzO type I toxin-antitoxin locus: repression by the OrzO antitoxin. Nucleic Acids Res (2013) 0.84
Population dynamics of bacterial persistence. PLoS One (2013) 0.84
Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms. Sci Rep (2015) 0.83
Post-transcriptional regulation of gene expression in bacterial pathogens by toxin-antitoxin systems. Front Cell Infect Microbiol (2014) 0.83
A screen for and validation of prodrug antimicrobials. Antimicrob Agents Chemother (2013) 0.83
Ranking of persister genes in the same Escherichia coli genetic background demonstrates varying importance of individual persister genes in tolerance to different antibiotics. Front Microbiol (2015) 0.82
The HigB/HigA toxin/antitoxin system of Pseudomonas aeruginosa influences the virulence factors pyochelin, pyocyanin, and biofilm formation. Microbiologyopen (2016) 0.82
A moderate toxin, GraT, modulates growth rate and stress tolerance of Pseudomonas putida. J Bacteriol (2013) 0.81
Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringens. BMC Microbiol (2013) 0.81
Anti-biofilm Activity as a Health Issue. Front Microbiol (2016) 0.81
The formation of Streptococcus mutans persisters induced by the quorum-sensing peptide pheromone is affected by the LexA regulator. J Bacteriol (2015) 0.81
Molecular basis of ribosome recognition and mRNA hydrolysis by the E. coli YafQ toxin. Nucleic Acids Res (2015) 0.80
Classic reaction kinetics can explain complex patterns of antibiotic action. Sci Transl Med (2015) 0.80
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol (2006) 40.15
Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50
Bacterial persistence as a phenotypic switch. Science (2004) 15.80
Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res (1997) 13.15
A common mechanism of cellular death induced by bactericidal antibiotics. Cell (2007) 12.92
Prokaryotic toxin-antitoxin stress response loci. Nat Rev Microbiol (2005) 9.08
Persister cells, dormancy and infectious disease. Nat Rev Microbiol (2006) 8.35
Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res (2005) 6.61
Comparative gene expression profiles following UV exposure in wild-type and SOS-deficient Escherichia coli. Genetics (2001) 6.29
Conditional-replication, integration, excision, and retrieval plasmid-host systems for gene structure-function studies of bacteria. J Bacteriol (2001) 5.87
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol (2004) 5.82
Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett (2004) 5.23
Identification of additional genes belonging to the LexA regulon in Escherichia coli. Mol Microbiol (2000) 5.08
Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol (2001) 4.49
Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell (2008) 4.47
Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother (1999) 4.23
SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science (2004) 4.20
RelE, a global inhibitor of translation, is activated during nutritional stress. Proc Natl Acad Sci U S A (2001) 4.10
Persisters: a distinct physiological state of E. coli. BMC Microbiol (2006) 4.03
A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat Methods (2006) 3.95
DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. J Mol Biol (1996) 3.08
Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu Rev Microbiol (1998) 3.04
Quinolone-mediated bacterial death. Antimicrob Agents Chemother (2007) 2.94
Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol (2003) 2.92
Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet (2009) 2.89
The small RNA IstR inhibits synthesis of an SOS-induced toxic peptide. Curr Biol (2004) 2.85
Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science (2009) 2.74
Spontaneous DNA breakage in single living Escherichia coli cells. Nat Genet (2007) 2.64
The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther (2007) 2.59
Mechanism of postsegregational killing by the hok gene product of the parB system of plasmid R1 and its homology with the relF gene product of the E. coli relB operon. EMBO J (1986) 2.54
Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother (2008) 2.40
Plant defense peptides. Biopolymers (1998) 2.36
Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother (1987) 2.31
What is the benefit to Escherichia coli of having multiple toxin-antitoxin systems in its genome? J Bacteriol (2007) 2.29
SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet (2009) 2.28
Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob Agents Chemother (2005) 2.20
Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J Bacteriol (2006) 2.19
Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol (2006) 2.17
An antisense RNA controls synthesis of an SOS-induced toxin evolved from an antitoxin. Mol Microbiol (2007) 2.11
Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis (2001) 2.05
Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J Bacteriol (2006) 2.04
An antisense RNA inhibits translation by competing with standby ribosomes. Mol Cell (2007) 1.97
Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc Natl Acad Sci U S A (1986) 1.94
Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob Agents Chemother (1998) 1.92
Conditional impairment of cell division and altered lethality in hipA mutants of Escherichia coli K-12. J Bacteriol (1988) 1.90
Multiple hok genes on the chromosome of Escherichia coli. Mol Microbiol (1999) 1.79
GlpD and PlsB participate in persister cell formation in Escherichia coli. J Bacteriol (2006) 1.66
The bactericidal action of penicillin: new clues to an unsolved mystery. Trends Microbiol (2000) 1.49
A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol Microbiol (2008) 1.48
The dinB operon and spontaneous mutation in Escherichia coli. J Bacteriol (2003) 1.46
Chromosomal toxin-antitoxin systems may act as antiaddiction modules. J Bacteriol (2008) 1.46
Escherichia coli dinJ-yafQ genes act as a toxin-antitoxin module. FEMS Microbiol Lett (2007) 1.44
Hydrophobic peptides: novel regulators within bacterial membrane. Mol Microbiol (2009) 1.26
Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol Lett (2009) 1.20
Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics. J Infect Dis (2009) 1.18
An SOS-regulated type 2 toxin-antitoxin system. J Bacteriol (2009) 1.09
Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli. FEMS Microbiol Lett (2005) 1.03
Lethal action of quinolones against a temperature-sensitive dnaB replication mutant of Escherichia coli. Antimicrob Agents Chemother (2006) 1.02
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol (2004) 5.82
Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett (2004) 5.23
Persisters: a distinct physiological state of E. coli. BMC Microbiol (2006) 4.03
Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95
Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science (2013) 2.97
Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science (2009) 2.74
Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother (2008) 2.40
Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS (2002) 2.40
SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet (2009) 2.28
Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother (2006) 2.18
Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol (2010) 2.11
Siderophores from neighboring organisms promote the growth of uncultured bacteria. Chem Biol (2010) 2.04
Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J Bacteriol (2006) 2.04
Incubation of environmental samples in a diffusion chamber increases the diversity of recovered isolates. Appl Environ Microbiol (2007) 2.03
High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol (2009) 1.99
Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci U S A (2006) 1.98
Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob Agents Chemother (2002) 1.96
Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol (2003) 1.84
A problem of persistence: still more questions than answers? Nat Rev Microbiol (2013) 1.68
GlpD and PlsB participate in persister cell formation in Escherichia coli. J Bacteriol (2006) 1.66
Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio (2011) 1.64
Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile. Antimicrob Agents Chemother (2004) 1.55
Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother (2009) 1.46
Role of oxidative stress in persister tolerance. Antimicrob Agents Chemother (2012) 1.40
Staphylococcus aureus persisters tolerant to bactericidal antibiotics. J Mol Microbiol Biotechnol (2012) 1.25
Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial. ACS Chem Biol (2006) 1.24
Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria. PLoS One (2011) 1.21
Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings. J Clin Microbiol (2005) 1.21
Immobilized N-alkylated polyethylenimine avidly kills bacteria by rupturing cell membranes with no resistance developed. Biotechnol Bioeng (2005) 1.19
Polymer surfaces derivatized with poly(vinyl-N-hexylpyridinium) kill airborne and waterborne bacteria. Biotechnol Bioeng (2002) 1.14
Bactericidal properties of flat surfaces and nanoparticles derivatized with alkylated polyethylenimines. Biotechnol Prog (2002) 1.12
Isolation and physiology of bacteria from contaminated subsurface sediments. Appl Environ Microbiol (2010) 1.12
Mechanism of bactericidal and fungicidal activities of textiles covalently modified with alkylated polyethylenimine. Biotechnol Bioeng (2003) 1.09
A trap for in situ cultivation of filamentous actinobacteria. J Microbiol Methods (2008) 1.05
Pseudomonas aeruginosa biofilms in disease. Microb Ecol (2013) 1.02
Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria. J Nat Prod (2004) 1.01
Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors. Bioorg Med Chem (2005) 1.00
Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus. Planta Med (2002) 0.96
Regulation of the Escherichia coli HipBA toxin-antitoxin system by proteolysis. PLoS One (2012) 0.96
Tolerance of Escherichia coli to fluoroquinolone antibiotics depends on specific components of the SOS response pathway. Genetics (2013) 0.95
Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms. J Antimicrob Chemother (2011) 0.95
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus. J Nat Prod (2006) 0.95
Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group. Bioorg Med Chem (2009) 0.94
Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus. Bioorg Med Chem Lett (2008) 0.91
Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence. J Acquir Immune Defic Syndr (2008) 0.88
Berberine-INF55 (5-nitro-2-phenylindole) hybrid antimicrobials: effects of varying the relative orientation of the berberine and INF55 components. Antimicrob Agents Chemother (2010) 0.88
Role of unusual P loop ejection and autophosphorylation in HipA-mediated persistence and multidrug tolerance. Cell Rep (2012) 0.87
Persister-promoting bacterial toxin TisB produces anion-selective pores in planar lipid bilayers. FEBS Lett (2012) 0.87
Isoflavones as potentiators of antibacterial activity. J Agric Food Chem (2003) 0.86
Potentiation of azole antifungals by 2-adamantanamine. Antimicrob Agents Chemother (2013) 0.84
Persister cells in biofilm associated infections. Adv Exp Med Biol (2015) 0.83
A screen for and validation of prodrug antimicrobials. Antimicrob Agents Chemother (2013) 0.83
Erratum: A new antibiotic kills pathogens without detectable resistance. Nature (2015) 0.83
Polyacylated neohesperidosides from Geranium caespitosum: bacterial multidrug resistance pump inhibitors. Bioorg Med Chem Lett (2003) 0.82
Persister eradication: lessons from the world of natural products. Methods Enzymol (2012) 0.81
Prokaryotic real-time gene expression profiling for toxicity assessment. Environ Sci Technol (2009) 0.78
Drastically lowering the titer of waterborne bacteriophage PRD1 by exposure to immobilized hydrophobic polycations. Biotechnol Lett (2004) 0.75